Intel, Optum, Relyens and Rezayat Group all invested in the surgery software provider, which is also backed by Mitsubishi, Barco Healthcare, Norgine and Takeda.
US-based surgical software and automation technology provider Caresyntax completed a $100m series C round yesterday featuring semiconductor technology producer Intel, healthcare services provider Optum, insurer Relyens and conglomerate Rezayat Group.
The round was led by investment manager PFM Health Sciences and included asset manager Lauxera Capital Partners, life science-focused fund Vesalius Biocapital III, credit fund Arno Capital, venture capital fund Surgical.AI and alternative finance provider IPF Partners.
Intel, Optum and Rezayat Group, were represented by their respective corporate venturing subsidiaries:…
